Psychiatry – Heveren-Healthcare https://heveren.com Trusted pharmaceutical solutions for a healthier tomorrow Mon, 07 Apr 2025 07:55:07 +0000 en-US hourly 1 https://heveren.com/wp-content/uploads/2022/06/cropped-theveren-logo-32x32.png Psychiatry – Heveren-Healthcare https://heveren.com 32 32 DEXFIN https://heveren.com/product/dexfin/ Sat, 05 Apr 2025 11:07:38 +0000 https://heveren.com/?post_type=product&p=1089 Indication : In Major Depressive disorder.

Major Depressive Disorder is a serious mental health condition characterized by persistent sadness, loss of interest in activities, and impaired daily functioning. It differs from normal sadness by its severity, duration (symptoms last ≥2 weeks), and significant impact on life

MOA : The clinical effect of desvenlafaxine occurs via potentiation of serotonin and norepinephrine in CNS.

]]>
ESCIREN LITE/PLUS https://heveren.com/product/esciren-lite-plus/ Sat, 05 Apr 2025 11:00:43 +0000 https://heveren.com/?post_type=product&p=1087 Indication : In Depression and Anxiety.

Depression is a mood disorder characterized by low mood, a feeling of sadness and a general loss of interest in things.

Anxiety is a normal emotion that causes increased alertness, fear and physical signs, such as a rapid heart rate.

MOA : Escitalopram reduces depression by inhibiting CNS neuronal reuptake of serotonin. Clonazepam enhances the activity of GABA.

]]>
ESCIREN https://heveren.com/product/esciren/ Sat, 05 Apr 2025 10:53:20 +0000 https://heveren.com/?post_type=product&p=1081 Indication : In Depression and Anxiety

Depression is a mood disorder characterized by low mood, a feeling of sadness and a general loss of interest in things.

Anxiety is a normal emotion that causes increased alertness, fear and physical signs, such as a rapid heart rate.

MOA : It reduces depression by inhibiting CNS neuronal reuptake of serotonin.

]]>